{"id":"https://openalex.org/W7225820340","doi":"https://doi.org/10.3389/fmicb.2026.1903280","title":"Genotypic drug resistance characteristics and their clinical guiding value in people living with HIV","display_name":"Genotypic drug resistance characteristics and their clinical guiding value in people living with HIV","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7225820340","doi":"https://doi.org/10.3389/fmicb.2026.1903280"},"language":"en","primary_location":{"id":"doi:10.3389/fmicb.2026.1903280","doi":"https://doi.org/10.3389/fmicb.2026.1903280","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2026.1903280","pdf_url":null,"source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fmicb.2026.1903280","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076238537","display_name":"Mengze Gan","orcid":"https://orcid.org/0000-0002-9663-6737","observed_orcids":["https://orcid.org/0000-0002-9663-6737"]},"institutions":[{"id":"https://openalex.org/I4210133959","display_name":"The Second Nanning People's Hospital","ror":"https://ror.org/02qmhct90","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133959"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Mengze Gan","raw_affiliation_strings":["HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning","institution_ids":["https://openalex.org/I4210133959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161454592","display_name":"Qiuying Ma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133959","display_name":"The Second Nanning People's Hospital","ror":"https://ror.org/02qmhct90","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133959"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qiuying Ma","raw_affiliation_strings":["HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning","institution_ids":["https://openalex.org/I4210133959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161490701","display_name":"Cailing Wei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133959","display_name":"The Second Nanning People's Hospital","ror":"https://ror.org/02qmhct90","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133959"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Cailing Wei","raw_affiliation_strings":["HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning","institution_ids":["https://openalex.org/I4210133959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111238528","display_name":"Manqi Xiao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133959","display_name":"The Second Nanning People's Hospital","ror":"https://ror.org/02qmhct90","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133959"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Manqi Xiao","raw_affiliation_strings":["HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning","institution_ids":["https://openalex.org/I4210133959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161463091","display_name":"Yuliang Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133959","display_name":"The Second Nanning People's Hospital","ror":"https://ror.org/02qmhct90","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133959"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuliang Huang","raw_affiliation_strings":["HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning","institution_ids":["https://openalex.org/I4210133959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005536993","display_name":"\u8d3a\u671d\u52c7","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133959","display_name":"The Second Nanning People's Hospital","ror":"https://ror.org/02qmhct90","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133959"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chaoyong He","raw_affiliation_strings":["HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning","institution_ids":["https://openalex.org/I4210133959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161476879","display_name":"Yanjun Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133959","display_name":"The Second Nanning People's Hospital","ror":"https://ror.org/02qmhct90","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133959"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yanjun Li","raw_affiliation_strings":["HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning","institution_ids":["https://openalex.org/I4210133959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103048423","display_name":"Jun Zou","orcid":"https://orcid.org/0000-0002-9633-1714","observed_orcids":["https://orcid.org/0000-0002-9633-1714"]},"institutions":[{"id":"https://openalex.org/I4210133959","display_name":"The Second Nanning People's Hospital","ror":"https://ror.org/02qmhct90","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133959"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jun Zou","raw_affiliation_strings":["HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning","institution_ids":["https://openalex.org/I4210133959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045135674","display_name":"\u738b\u771f\u884c","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133959","display_name":"The Second Nanning People's Hospital","ror":"https://ror.org/02qmhct90","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210133959"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Zhenxing Wang","raw_affiliation_strings":["HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV/AIDS Clinical Treatment Center of Guangxi (Nanning) and The Fourth People's Hospital of Nanning","institution_ids":["https://openalex.org/I4210133959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046107390","display_name":"Zhangwen Ge","orcid":"https://orcid.org/0000-0001-6817-6473","observed_orcids":["https://orcid.org/0000-0001-6817-6473"]},"institutions":[{"id":"https://openalex.org/I4210154454","display_name":"Guizhou Provincial People's Hospital","ror":"https://ror.org/046q1bp69","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210154454"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Zhangwen Ge","raw_affiliation_strings":["Department of Laboratory Medicine, Guizhou Provincial People's Hospital, Guiyang"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, Guizhou Provincial People's Hospital, Guiyang","institution_ids":["https://openalex.org/I4210154454"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5045135674","https://openalex.org/A5046107390"],"corresponding_institution_ids":["https://openalex.org/I4210133959","https://openalex.org/I4210154454"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.7825999855995178},{"id":"https://openalex.org/C2778451633","wikidata":"https://www.wikidata.org/wiki/Q5629934","display_name":"HIV drug resistance","level":5,"score":0.7775999903678894},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6269999742507935},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.6237000226974487},{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.5394999980926514},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4797999858856201},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.47769999504089355},{"id":"https://openalex.org/C761482","wikidata":"https://www.wikidata.org/wiki/Q118093","display_name":"Transmission (telecommunications)","level":2,"score":0.4505000114440918},{"id":"https://openalex.org/C57473165","wikidata":"https://www.wikidata.org/wiki/Q7315604","display_name":"Resistance (ecology)","level":2,"score":0.40290001034736633},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3953999876976013},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.38670000433921814},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.36880001425743103},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3547999858856201},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35100001096725464},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.328900009393692},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.3165999948978424},{"id":"https://openalex.org/C63363279","wikidata":"https://www.wikidata.org/wiki/Q5133848","display_name":"Clinical significance","level":2,"score":0.3095000088214874},{"id":"https://openalex.org/C2909970146","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Nucleoside Reverse Transcriptase Inhibitor","level":5,"score":0.30239999294281006},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28839999437332153},{"id":"https://openalex.org/C149172746","wikidata":"https://www.wikidata.org/wiki/Q2585693","display_name":"Efficacy","level":3,"score":0.27959999442100525},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2667999863624573},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.26589998602867126},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.26579999923706055},{"id":"https://openalex.org/C2776452011","wikidata":"https://www.wikidata.org/wiki/Q311463","display_name":"Sida","level":4,"score":0.26080000400543213},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.25690001249313354},{"id":"https://openalex.org/C2777286243","wikidata":"https://www.wikidata.org/wiki/Q5591926","display_name":"Grading (engineering)","level":2,"score":0.2502000033855438}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fmicb.2026.1903280","doi":"https://doi.org/10.3389/fmicb.2026.1903280","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2026.1903280","pdf_url":null,"source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fmicb.2026.1903280","doi":"https://doi.org/10.3389/fmicb.2026.1903280","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmicb.2026.1903280","pdf_url":null,"source":{"id":"https://openalex.org/S2484704948","display_name":"Frontiers in Microbiology","issn_l":"1664-302X","issn":["1664-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Microbiology","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1967361474","https://openalex.org/W1972322103","https://openalex.org/W2061537384","https://openalex.org/W2069388608","https://openalex.org/W2125377515","https://openalex.org/W3008969995","https://openalex.org/W3012702805","https://openalex.org/W3090177509","https://openalex.org/W3091955100","https://openalex.org/W3093940905","https://openalex.org/W3123817948","https://openalex.org/W4205856539","https://openalex.org/W4389792782","https://openalex.org/W4396774768","https://openalex.org/W4397007118","https://openalex.org/W4400967866","https://openalex.org/W4401931029","https://openalex.org/W4402077536","https://openalex.org/W4403538239","https://openalex.org/W4408236111","https://openalex.org/W4409877409","https://openalex.org/W4414160767","https://openalex.org/W4414982642","https://openalex.org/W4415209965","https://openalex.org/W4416355729","https://openalex.org/W7104177037","https://openalex.org/W7127882317"],"related_works":[],"abstract_inverted_index":{"Objective":[0],"Genotypic":[1],"drug":[2,54,61,87],"resistance":[3,39,55,62,65,67,88,114,135,140,181,186],"testing":[4,56],"plays":[5],"a":[6,24],"critical":[7],"role":[8],"in":[9,180],"guiding":[10],"antiretroviral":[11],"therapy":[12],"(ART)":[13],"for":[14,197],"people":[15],"living":[16],"with":[17,73,146,166],"HIV":[18,52,204],"(PLWH).":[19],"However,":[20],"current":[21],"studies":[22],"lack":[23],"stratified":[25,171],"quantitative":[26],"framework":[27,173],"to":[28,59,153],"evaluate":[29],"its":[30],"clinical":[31,79,147,199],"utility,":[32],"which":[33],"hinders":[34],"the":[35,78,175],"precise":[36],"translation":[37],"of":[38,81,119,177],"data":[40],"into":[41],"routine":[42],"practice.":[43],"Methods":[44],"In":[45],"this":[46],"study,":[47],"274":[48],"PLWH":[49],"who":[50],"underwent":[51],"genotypic":[53,82,139],"were":[57,126,143,164],"enrolled":[58],"characterize":[60],"profiles,":[63],"subtype-specific":[64,123],"heterogeneity,":[66],"transmission":[68,118],"clusters,":[69],"and":[70,99,116,130,157,193,202],"metabolic":[71,124],"features,":[72],"particular":[74],"emphasis":[75],"on":[76],"grading":[77],"utility":[80],"resistance.":[83],"Results":[84],"The":[85,105],"overall":[86],"rate":[89],"was":[90],"24.09%,":[91],"predominantly":[92],"involving":[93],"non-nucleoside":[94],"reverse":[95,101],"transcriptase":[96,102],"inhibitors":[97,103],"(NNRTIs)":[98],"nucleoside":[100],"(NRTIs).":[104],"three":[106],"major":[107],"locally":[108],"circulating":[109],"recombinant":[110],"subtypes":[111],"showed":[112],"distinct":[113],"spectra":[115],"active":[117],"resistant":[120],"strains,":[121],"whereas":[122,160],"variations":[125],"confounded":[127],"by":[128],"demographic":[129],"immunological":[131],"factors":[132],"rather":[133],"than":[134],"mutations.":[136],"Notably,":[137],"graded":[138],"guidance":[141,150,162],"values":[142,151,163],"closely":[144],"associated":[145,165],"outcomes:":[148],"stronger":[149],"corresponded":[152],"better":[154],"virological":[155],"suppression":[156],"CD4":[158],"recovery,":[159],"weaker":[161],"poorer":[167],"prognosis.":[168],"Conclusions":[169],"This":[170],"evaluation":[172,187],"improves":[174],"interpretation":[176],"genotype-phenotype":[178],"discordance":[179],"assessment,":[182],"helps":[183],"refine":[184],"standardized":[185],"criteria,":[188],"supports":[189],"individualized":[190],"ART":[191],"decision-making,":[192],"provides":[194],"real-world":[195],"evidence":[196],"optimizing":[198],"management":[200],"strategies":[201],"targeted":[203],"treatment":[205],"policies.":[206]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}